Defactinib
About
Therapy type: Targeted therapy
Therapy strategy: FAK inhibition
Mappings
NCI Thesaurus: Defactinib (coding:ncit:C79809)
RxNorm: defactinib (coding:rxcui:2714502, coding:omop:37353190)
Therapeutic response
Precision oncology relationships for therapeutic response involving this therapy.
| Organizations | Biomarkers | Cancer types | Therapies | |
|---|---|---|---|---|
| FDA (1) | KRAS p.G12C | Low-Grade Serous Ovarian Cancer | Avutometinib, Defactinib | |
| FDA (1) | KRAS p.G12V | Low-Grade Serous Ovarian Cancer | Avutometinib, Defactinib |